Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLB vs MRNA✓SelectedUSD · MRNAXLB vs MRNA performance historyLatest closeAs of-2.06%11/19
Stock and ETF performance explorer

XLB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1.6%
MRNA return
+318.7%
Excess return
-317.1%
Maximum drawdown
-9.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.1%+1.3%-3.4%-2.1%
7D-5.6%-13.8%+8.3%-5.4%
30D-3.5%-17.7%+14.1%-3.3%
3M-5.5%+14.3%-19.8%-5.7%
6M+1.6%+336.0%-334.4%-3.4%
All+1.6%+318.7%-317.1%-3.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling